6533b857fe1ef96bd12b4eda
RESEARCH PRODUCT
Putting the “bio” in “biotherapeutics”/checkpoints for biosimilars/application of biosimilars
Lluís PuigJuan V. EspluguesBruno Flamionsubject
Executive summarybusiness.industryImmunologylcsh:RMedical practicelcsh:MedicineBiosimilarCell BiologyPharmacologyApplied Microbiology and BiotechnologyMicrobiologyRisk analysis (engineering)GeneticsMolecular MedicineMedicinebusinessMolecular Biologydescription
Abstract / Executive summary The number of biosimilar medicines on the market is steadily increasing, due, in part, to patent expiration of several top-selling biologic medicines. These three e-learning modules discuss the basic concepts behind biosimilar medicines and highlight key regulatory considerations when using biosimilar medicines in medical practice.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-12-01 | European Journal of Molecular and Clinical Medicine |